Council Visits Capitol Hill to Discuss Prescription Drug Costs in the U.S. Health Care System
The Health Practice Council gave a briefing on Capitol Hill to policymakers and congressional and federal agency staff, offering expertise on the drivers of growth in drug expenses; benefits versus costs for new treatments; the impact of high and increasing prescription drug costs on payers; and options to address spending.
Work Group Publishes Issue Brief on Prescription Drug Spending
The Prescription Drug Work Group published an issue brief highlighting prescription drug issues present in our health care system, including cost drivers, the effect on various stakeholders, and possible approaches that might help address the health care cost growth associated with prescription drugs.
Committee Sends Comments on Association Health Plans
The Individual and Small Group Markets Committee sent comments to the U.S. Department of Labor on proposed rules regarding the definition of ‘‘Employer’’ under section 3(5) of ERISA—Association Health Plans.
Work Group Submits Comment Letter to NAIC on VA QIS II Recommendations vF
The AG43/C3P2 Work Group submitted a comment letter to the NAIC's Variable Annuities (E) Working Group on proposed modifications to Actuarial Guideline XLIII (AG43) and C-3 Phase II (C3P2).
Council Sends Comments to Idaho Department of Insurance
The Health Practice Council sent comments to the Idaho Department of Insurance on allowing health insurers to offer state-based plans that are not compliant with the Affordable Care Act in Idaho.
Health Paper Offers an Actuarial Look at High-Performance Networks
The High-Performance Network Work Group of the American Academy of Actuaries has released a new issue paper, High-Performance Networks. Drawing on recent public policy debates about addressing health care spending, this paper explores the expansion of high-performance networks (HPNs) which generally focus on delivering high-quality and efficient care, as a potential solution.
